Highest-materiality recent filing
CEO Daniel Reis-Faria received 500,000 options, CFO Dany Vaiman 250,000, Executive Chairman Michael Heinrich 500,000.
ZeroStack to issue shares for 142M Zero Gravity tokens, settles convertible note
Texas Blocker issued 9.1M shares in exchange for 142M 0G tokens valued at ~$107M (Token FMV $0.7549).
Settlement requires Jan 6, 2026 payment of 96,162 Solana, $1.75M cash, 111,550 shares at $6.90/share.
Shareholders approved name change to 'ZeroStack Corp.' and creation of a new class of preferred shares.
Flora Growth enters $25M equity purchase agreement with White Lion Capital, expandable to $50M
Up to $25M initial commitment, expandable to $50M at company's discretion over 24 months.
Flora Growth reports over $401M in funding for ZeroStack; $0G token launched
Over $401M secured via $0G tokens, convertible notes, cash raise of $13.66M, and $22.88M in SOL.
Flora Growth files ATM prospectus to sell up to $3.45M in common shares
New ATM agreement with Revere Securities allows sale of up to $3,450,000 of common shares.
Flora Growth raises ~$402M in placements, exits cannabis, pivots to digital asset treasury
CEO Clifford Starke and Executive Chairman Sammy Dorf resigned; replaced by Daniel Reis-Faria (CEO) and Michael Heinrich (Executive Chairman).
Flora Growth board loses independent director majority after passing of Harold Wolkin
Director Harold Wolkin passed away August 25, 2025; he served on audit, compensation, and nominating committees.
Flora Growth completes 1-for-39 reverse stock split effective August 3, 2025
Share consolidation at 1-for-39 ratio, approved by board on July 10, 2025.
Proposal 4 (grant of Stock Appreciation Rights to CEO, CFO, Executive Chairman) rejected with 7.5M against vs 1.3M for.
Flora Growth raises $1.1M via private placement; funds to buy crypto assets
Issued 3,133,011 common shares at $0.30 and 726,992 pre-funded warrants at $0.2999.
Flora Growth receives Nasdaq delisting notice for failing $1.00 minimum bid price
Nasdaq notified Flora Growth on Feb 25, 2025 of non-compliance with $1.00 minimum bid price over 30 consecutive business days.
Flora Growth acquires United Beverage for $2.85M notes and 4.99% stock; insiders included as sellers
Acquired 100% of United Beverage Distribution Inc., a cannabis-infused drink distributor, for $2,845,700 in 5-year 6% notes and 923,744 Flora shares (4.99% of outstanding).
Flora Growth raises ~$3.6M in registered direct offering of 2.85M shares at $1.25/share
Net proceeds of approximately $3.1M after deducting placement fees and estimated expenses.
Flora Growth appoints Sammy Dorf as Executive Chairman, adds independent director
Director Brendan Cahill resigned on Dec 5, 2024; no disagreement with company.
Flora Growth acquires TruHC Pharma; TruHC audit shows going concern, minimal cash
TruHC Pharma GmbH acquired; first closing completed April 23, 2024.
Flora Growth completes first closing of TruHC Pharma acquisition; issues 2.14M shares worth ~$4.9M
First closing of TruHC Pharma GmbH acquisition; issued 2,135,199 common shares.
Flora Growth announces $3.23M public offering of 1.7M shares at $1.90 each
Underwriting agreement with Aegis Capital Corp. for 1,700,000 common shares at $1.90/share.
Flora Growth to acquire TruHC Pharma GmbH for $6.4M in stock
Purchase price of US$6,400,000 payable in 2,770,562 FLGC common shares.
On August 29, 2024, the Board appointed Mr. Harold Wolkin as an independent director and member of each of the Company's audit committee, compensation committee and nominating and corporate governance committee.
On August 26, 2024, Mr. Kevin Taylor resigned as a director of the Company.
On May 2, 2024, the Board of Directors (the " Board ") of Flora Growth Corp. (the " Company ") appointed Mr. Brendan Cahill as an independent director and member of each of the Company's audit committee, compensation committee and nominating and corporate governance committee.
Max materiality 0.95 · Median 0.60 · Most common event other_material